期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 15, 期 3, 页码 339-348出版社
TAYLOR & FRANCIS AS
DOI: 10.1586/14737159.2015.1002469
关键词
Alzheimer's disease; diagnosis; genomics; prognosis; therapy
类别
资金
- Paul B. Beeson Career Development Award [K23AG034550]
Alzheimer's disease (AD), the most common form of dementia in western societies, is a pathologically and clinically heterogeneous disease with a strong genetic component. The recent advances in high-throughput genome technologies allowing for the rapid analysis of millions of polymorphisms in thousands of subjects has significantly advanced our understanding of the genomic underpinnings of AD susceptibility. During the last 5 years, genome-wide association and whole-exome- and whole-genome sequencing studies have mapped more than 20 disease-associated loci, providing insights into the molecular pathways involved in AD pathogenesis and hinting at potential novel therapeutic targets. This review article summarizes the challenges and opportunities of when using genomic information for the diagnosis and prognosis of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据